Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (921-930 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|March 3, 2018
Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumorsKazuhiko Hayashi, Naoyoshi Yamamoto, Masataka Karube, et al.
Cancer Science|January 17, 2018
Drug resistance in anaplastic lymphoma kinase-rearranged lung cancerRyohei Katayama
Cancer Science|February 16, 2018
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitorChengying Xie, Xiaozhe Wan, Haitian Quan, et al.
Cancer Science|February 1, 2018
Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxiaXiangqiang Liu, Yafang Wang, Li Sun, et al.
Cancer Science|February 2, 2018
Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapyNaoki Sakuyama, Motohiro Kojima, Shingo Kawano, et al.
Cancer Science|November 9, 2017
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trialsAkihiro Hirakawa, Kan Yonemori, Fumie Kinoshita, et al.
Cancer Science|November 11, 2017
Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patientsXuanye Zhang, Huilan Rao, Xiaolu Xu, et al.
Cancer Science|November 10, 2017
Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabineMasafumi Ikeda, Tatsuya Ioka, Akira Fukutomi, et al.
Cancer Science|November 10, 2017
Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B virusesHironori Nishitsuji, Keisuke Harada, Saneyuki Ujino, et al.
Cancer Science|January 25, 2018
Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomasYu Uemura, Yasushi Isobe, Akiko Uchida, et al.
Pageof 695

Showing results (921-930 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|March 3, 2018
Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumorsKazuhiko Hayashi, Naoyoshi Yamamoto, Masataka Karube, et al.
Cancer Science|January 17, 2018
Drug resistance in anaplastic lymphoma kinase-rearranged lung cancerRyohei Katayama
Cancer Science|February 16, 2018
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitorChengying Xie, Xiaozhe Wan, Haitian Quan, et al.
Cancer Science|February 1, 2018
Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxiaXiangqiang Liu, Yafang Wang, Li Sun, et al.
Cancer Science|February 2, 2018
Area of residual tumor is a robust prognostic marker for patients with rectal cancer undergoing preoperative therapyNaoki Sakuyama, Motohiro Kojima, Shingo Kawano, et al.
Cancer Science|November 9, 2017
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trialsAkihiro Hirakawa, Kan Yonemori, Fumie Kinoshita, et al.
Cancer Science|November 11, 2017
Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patientsXuanye Zhang, Huilan Rao, Xiaolu Xu, et al.
Cancer Science|November 10, 2017
Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabineMasafumi Ikeda, Tatsuya Ioka, Akira Fukutomi, et al.
Cancer Science|November 10, 2017
Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B virusesHironori Nishitsuji, Keisuke Harada, Saneyuki Ujino, et al.
Cancer Science|January 25, 2018
Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomasYu Uemura, Yasushi Isobe, Akiko Uchida, et al.
Pageof 695